Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) General Information

Description

License for ISIS-FXIRx, an experimental anticoagulant drug of a pharmaceutical company, based in Carlsbad, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • 2855 Gazelle Court
  • Carlsbad, CA 92010
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)‘s full profile, request access.

Request a free trial

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)‘s full profile, request access.

Request a free trial